Clinical Report: Evaluating the Relationship Between Systemic Lupus Erythematosus and Glaucoma
Overview
This meta-analysis evaluates the association between systemic lupus erythematosus (SLE) and glaucoma. The analysis included five cohort studies with a total of 5,516,709 participants.
Background
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can lead to various ocular manifestations, affecting approximately one-third of patients. Glaucoma, a leading cause of irreversible vision loss, may be a risk for SLE patients, particularly due to the effects of long-term glucocorticoid treatment.
Data Highlights
Measure
Value
Odds Ratio (OR)
2.85
95% Confidence Interval (CI)
1.26–6.47
P-value
0.01
Key Findings
SLE is associated with an increased risk of glaucoma (OR = 2.85, 95% CI: 1.26–6.47).
The meta-analysis included five cohort studies with a total of 5,516,709 participants.
Stronger associations were observed in studies with fewer covariate adjustments.
Studies not adjusting for corticosteroid use showed a higher risk association.
More prospective studies are needed to confirm these findings and control for confounding factors.
Clinical Implications
Healthcare providers should be aware of the increased risk of glaucoma in SLE patients, particularly those on glucocorticoids.
Conclusion
The findings indicate an association between SLE and an increased risk of glaucoma.
